Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

ClinicalTrials.gov ID: NCT01663532

Public ClinicalTrials.gov record NCT01663532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 3:31 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the overall efficacy of aripiprazole intramuscular (IM) depot as acute treatment in subjects with schizophrenia. The secondary purpose is to evaluate the safety and tolerability of aripiprazole IM depot administered every 4 weeks for 12 weeks to adult subjects with schizophrenia.

Study identification

NCT ID
NCT01663532
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
340 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2012 (Type not available)
Primary completion
Aug 2013 (Actual)
Completion
Sep 2013 (Actual)
Last update posted
Feb 16, 2015

2012 – 2013

United States locations

U.S. sites
43
U.S. states
17
U.S. cities
35
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72201 —
Not listed Springdale Arkansas 72764 —
Not listed Anaheim California 92805 —
Not listed Carson California 90746 —
Not listed Escondido California 92025 —
Not listed Long Beach California 90806 —
Not listed Long Beach California 90813 —
Not listed National City California 91950 —
Not listed Oakland California 94612 —
Not listed Oceanside California 92056 —
Not listed Pico Rivera California 90660 —
Not listed San Diego California 92102 —
Not listed San Diego California 92123 —
Not listed Santa Ana California 92701 —
Not listed Sherman Oaks California 91403 —
Not listed Denver Colorado 80209 —
Not listed Washington D.C. District of Columbia 20016 —
Not listed Bradenton Florida 34208 —
Not listed Fort Lauderdale Florida 33301 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Fort Lauderdale Florida 33334 —
Not listed Hollywood Florida 33021 —
Not listed Kissimmee Florida 34741 —
Not listed Orlando Florida 32810 —
Not listed Atlanta Georgia 30308 —
Not listed Hoffman Estates Illinois 60169 —
Not listed Lake Charles Louisiana 70629 —
Not listed Flowood Mississippi 39232 —
Not listed Saint Charles Missouri 63304 —
Not listed St Louis Missouri 63118 —
Not listed St Louis Missouri 63128 —
Not listed St Louis Missouri 63141 —
Not listed Marlton New Jersey 08053 —
Not listed Holliswood New York 11423 —
Not listed Dayton Ohio 45417 —
Not listed Philadelphia Pennsylvania 19139 —
Not listed Charleston South Carolina 29407 —
Not listed Austin Texas 78731 —
Not listed Austin Texas 78754 —
Not listed Dallas Texas 75231 —
Not listed Dallas Texas 75243 —
Not listed Houston Texas 77007 —
Not listed Salt Lake City Utah 84106 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01663532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2015 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01663532 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →